Specialty code 183500000X · Sacramento, CA
NPI
1093227308
Since 2017
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2345 Fair Oaks Blvd
Sacramento, CA, 95825
Phone (916) 480-7056
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$319K
2,005 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Denny Woo prescribed most often to Medicare patients was Atorvastatin Calcium, with 284 prescriptions and refills. In total Denny Woo wrote 2,005 Medicare prescriptions that cost $319K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 284 | 944 | 121 | $3,480 |
| Metformin Hcl Er Metformin Hcl | 166 | 525 | 77 | $1,781 |
| Metformin Hcl Generic | 130 | 433 | 56 | $1,665 |
| Ozempic Semaglutide | 119 | 121 | 28 | $88K |
| Insulin Glargine-Yfgn Generic | 103 | 282 | 51 | $15K |
| Lisinopril Generic | 99 | 329 | 42 | $1,174 |
| Jardiance Empagliflozin | 93 | 277 | 36 | $51K |
| Glipizide Generic | 92 | 304 | 54 | $1,218 |
| Amlodipine Besylate Generic | 77 | 254 | 32 | $869 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 68 | 197 | 31 | $1,637 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 58 | 166 | 26 | $1,580 |
| Losartan Potassium Generic | 51 | 168 | 25 | $618 |
| Liraglutide Generic | 50 | 50 | 16 | $36K |
| Glipizide Er Glipizide | 49 | 161 | 20 | $1,919 |
| Hydrochlorothiazide Generic | 45 | 150 | 18 | $515 |
Brand drugs: 611 claims; generic drugs: 1,231 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Denny Woo were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.